http://stasf.com/making-calls/
The North Kansas City-based health care informatiob technology company, known mostly for the health-record softwars sold to hospitalsand clinics, is leveraginvg the billions of anonymous patient records it has at its disposal as marketablse information to pharmaceutical companies and researchers. Cernerr said the data operation is a big reasomn revenue for its LifeSciences Group has increasee by roughly 20 percent during each of the pastfive years. Mark the company’s life sciences solutions vice president, predicteed that annual growth will be greatere still inthe future. “This is just the beginning for us in the life he said. Included in Cerner’s data warehouse are 1.
2 billionn lab results. It also has smaller numbers of medicationm orders andother data. The companuy collects the informationthrough data-sharingy agreements with roughly 125 of its software By some estimates, it can take as long as 17 years and $1.2 billionh to develop a single Cerner’s data-mining capabilities can quicken that process and save monet for drug companies by helping the companiex establish a study protocol that maximizes the number of eligibl e candidates for a “We believe that can actually eventuallu reduce the cost of drug development,” Hoffman Cerner would not name its pharmaceutical Pharmaceutical companies and clinical researchers pay for Cerner data for othefr reasons, said Scott director of the ’s Office of Therapeutics Discoveryh and Development.
He said Cerner’s data-mining capabilityh can point scientists to potential new uses forexistinb drugs. For instance, Weir said, Cerner’s database mighrt suggest that a drug used to treat cardiovasculatr disease could be helpful in treating cancer Researchers then could run a clinical trial to test the The data is useful to drug companies for much the same Weir said, including helping them identifyu and correct side effects from The KU Cancer Center has used Cerner’s data-miningb capabilities for several projects. “They uncoved information we would never Weir said. “It’s invaluable.
” He said Cerner stands to benefit financially, as well, from collaborations with researcheres that can lead to intellectual property that producezs licensing feesand royalties. Cerner also can work with researchersz suchas Dr. Stephen director of the Center for Personalized Medicinse and Therapeutic Innovationat . Spielberg seekss a $3.9 million grant from the for a stud y of how the center can better captured data in pediatric cancer studies usingCerner software.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment